Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of HPV Integration on Prognosis of Young Women With CIN2 in China: A Multi-center Cohort Study in China

NCT05282095 is registered in ClinicalTrials.gov with Fujian Maternity and Child Health Hospital as lead sponsor.

NCT NCT05282095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China: A Multi-center Cohort Study in China
Lead sponsor
Fujian Maternity and Child Health Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2022
Completion date
May 31, 2026
Enrollment
300 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia, hpv infection, hsil, high grade squamous intraepithelial lesions, virus integration